The Technical AnalystExchange: Other OTC Sector: Healthcare Industry: Medical - Care Facilities
Bionik Laboratories Corp. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $0.0000
/ 29 nov 2023 @ 09:33
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 0.0000 mill |
| EPS: | -0.720 |
| P/E: | 0 |
| Earnings Date: | Feb 06, 2024 |
| SharesOutstanding: | 12.00 mill |
| Avg Daily Volume: | 0 mill |
| RATING 2023-11-13 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Sell | |
| P/E: | Neutral | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | n/a | |||||
| Gr.Profit | n/a | |||||
| Ebit | n/a | |||||
| Asset | n/a | |||||
| Debt | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE 0 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE 0 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0750 - 0.125 ( +/- 25.00%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-06-13 | Gaston-dreyfus Remi | Buy | 3 102 878 | Common Stock, par value $0.001 per share |
| 2023-06-13 | Auberton-herve Andre-jacques | Buy | 186 111 | Common Stock |
| 2023-06-13 | Auberton-herve Andre-jacques | Buy | 1 | Convertible Promissory Note |
| 2023-06-09 | Matine Charles | Buy | 180 555 | Common Stock, par value $0.001 per share |
| 2023-06-09 | Gaston-dreyfus Remi | Buy | 180 555 | Common Stock, par value $0.001 per share |
| INSIDER POWER |
|---|
| 96.55 |
| Last 89 transactions |
| Buy: 124 974 128 | Sell: 5 340 458 |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.0000 (0.00% ) |
| Volume | 0.0010 mill |
| Avg. Vol. | 0 mill |
| % of Avg. Vol | 0 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For BNKL
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
BNKL
Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.
Last 10 Buy Signals
Latest Press Releases
Latest News
